In vivo acute effects of orally administered hydro-ethanol extract of Catha edulis on blood glucose levels in normal, glucose-fed hyperglycemic, and alloxan-induced diabetic rats.
OBJECTIVE
To investigate the blood glucose lowering effect of khat (Catha edulis) extract in normal, glucose-loaded, and alloxan diabetic rats.


METHODS
Three experimental protocols were used in this study. In each of the first 2 protocols, 3 groups of rats (6 rats per group) were used as control group (NS), Catha edulis (CE) treated, and glibenclamide treated groups. This study was carried out at the Physiological Laboratory of the Medical School of King Khalid University, Abha, Saudi Arabia between October and November, 2009. Normal rats were used in the first protocol while alloxan diabetic rats were used in the second protocol. Blood glucose levels were measured in all 3 groups after single dose injections of saline, CE or glibenclamide. In the third protocol, another 6 groups of rats (6 rats per group) were prepared as in the first 2 protocols and oral glucose tolerance test (OGTT) was performed on each rat after oral administration of glucose (1.5 g/kg).


RESULTS
Oral administration of a hydro-ethanol extract of CE caused no statistically significant change in blood glucose levels in normal rats with or without glucose loading. There were slight, non significant increases in blood glucose levels of extract-treated diabetic rats, with and without glucose loading, as compared to the corresponding untreated rats.


CONCLUSIONS
Oral administration of CE extract does not exert a hypoglycemic effect in normal, glucose-loaded, and diabetic rats.
Dallak
Mohammad A
MA
Department of Physiology, College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Bin-Jaliah
Ismaeel
I
Al-Khateeb
Mahmoud A
MA
Nwoye
Luke O
LO
Shatoor
Abdullah S
AS
Soliman
Hesham S
HS
Al-Hashem
Fahaid H
FH
D000284:Administration, Oral; D000496:Alloxan; D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D029754:Catha / Q000737:chemistry*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D005947:Glucose / Q000008:administration & dosage*; D006943:Hyperglycemia / Q000188:drug therapy*; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats
D001786:Blood Glucose; D010936:Plant Extracts; D000496:Alloxan; D005947:Glucose